CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Antibody Type:
Monoclonal Antibody
Application Notes:
Flow Cytometry (1-2ug/million cells), ,Immunofluorescence (1-2ug/ml), ,Optimal dilution for a specific application should be determined.
Flow Cytometric Analysis of Raji cells. CD19 Mouse Monoclonal Antibody (CVID3/155) followed by go
Immunofluorescence staining of Raji cells. CD19 Mouse Monoclonal Antibody (CVID3/155) followed by goat anti-mouse IgG-CF488. Nuclear counterstain is RedDot.
Flow Cytometric Analysis of Raji cells. CD19 Mouse Monoclonal Antibody (CVID3/155) followed by goat anti-mouse IgG-CF488 (blue), isotype control (red).
SDS-PAGE Analysis of Purified CD19 Mouse Monoclonal Antibody (CVID3/155). Confirmation of Integrity and Purity of Antibody.
Flow cytometric analysis of lymphocyte-gated PBMCs. CD19 Mouse Monoclonal Antibody (CVID3/155) labeled with CF568 (orange), unstained cells (gray).
* VAT and and shipping costs not included. Errors and price changes excepted
